All Publications from Accelerate Diagnostics
Investor Relations
Investor Relations
Presentations & Press Releases
Stock Info
SEC Filings
Corporate Governance
Stock Info
Press Releases
Sep 16, 2020

Accelerate Diagnostics, Inc. (NASDAQ:AXDX) today announced that the Company has received U.S. Food and Drug Administration (FDA) clearance for a new suite of product enhancements to the Accelerate...

Sep 10, 2020

Accelerate Diagnostics, Inc. (NASDAQ:AXDX) and BioCheck, Inc., a privately-held San Francisco-based company focused on in vitro diagnostics, today announced that the U.S. Food and Drug...

Aug 24, 2020

Accelerate Diagnostics, Inc. (NASDAQ: AXDX) today announced that Nedal Safwat has been appointed Chief Strategy Officer. Dr. Safwat joins Accelerate from BioMerieux, the world's leading...

View all press releases

Upcoming Events
Thursday, August 6, 2020
4:30pm - 5:30pm EDT

To listen by phone Please dial in 10-15 minutes prior to the start of the conference. U.S. participants: 877.883.0383 International participants: +1.412.902.6506 Conference ID: 6487727 Conference...

View all events

Want to receive investor-related news and updates?